Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Maricef Vergara Rubio
Second Generation BTK Inhibitors Impair the Anti-Fungal Response of Macrophages and Neutrophils From CLL Patients
American Journal of Hematology
Hematology
Related publications
Second Cancer Incidence in CLL Patients Receiving BTK Inhibitors
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Acalabrutinib (ACP-196): A Selective Second-Generation BTK Inhibitor
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Toward Second-Generation Cardiomyogenic and Anti-Cardiofibrotic 1,4-Dihydropyridine-Class TGFβ Inhibitors
ChemMedChem
Organic Chemistry
Molecular Medicine
Pharmacology
Biochemistry
Toxicology
Drug Discovery
Pharmaceutics
BTK Inhibitor Ibrutinib in CLL and Mantle Cell Lymphoma
Community Oncology
Front Cover: Toward Second‐Generation Cardiomyogenic and Anti‐cardiofibrotic 1,4‐Dihydropyridine‐Class TGFβ Inhibitors (ChemMedChem 8/2019)
ChemMedChem
Organic Chemistry
Molecular Medicine
Pharmacology
Biochemistry
Toxicology
Drug Discovery
Pharmaceutics
Cell Line‐based Assessment of BTK Inhibitors
British Journal of Pharmacology
Pharmacology
Origins of Tumor-Associated Macrophages and Neutrophils
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Neutrophils and Macrophages: The Main Partners of Phagocyte Cell Systems
Frontiers in Immunology
Allergy
Immunology
IFN-γ and IL-17A Differentially Influence the Response of Human Macrophages and Neutrophils to Pseudomonas Aeruginosa Infection.
Infection and Immunity
Parasitology
Infectious Diseases
Immunology
Microbiology